To explore potential design for pharmacogenomics trials in sepsis, we investigate the interaction between pharmacogenomic biomarkers and response to drotrecogin alfa (activated) (DrotAA). This trial was desig...
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2nrlqbS
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Purpose Limited data are available on the relationship between treatment agents and sagittal balance in ankylosing spondylitis ...
-
Abstract The global incidence of very intense cyclones has increased in recent decades with climate projections signaling that this trend ...
-
No abstract available from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2iguS27
-
Background Traumatic diaphragm injuries (TDI) pose both diagnostic and therapeutic challenges in both the acute and chronic phases. There ar...
-
Objective: To evaluate the effect of routine use of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) on the diagnosis r...
-
Introduction Advancing age is a strong risk factor for adverse outcomes across multiple disease processes. However, septic surgical and trau...
-
Objectives: To review women’s participation as faculty at five critical care conferences over 7 years. Design: Retrospective analysis of fiv...
-
Objectives: To develop and validate an abbreviated version of the Cognitive Failure Questionnaire that can be used by patients as part of s...
-
Publication date: Available online 15 March 2018 Source: The Journal of Emergency Medicine Author(s): Eric J. Rebich, Stephanie S. Lee, J...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου